BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
  • Home
  • About Us
    • Richard Lowes
    • Bruce Dyer
    • David Gazzard
    • Andrew Atkinson
    • Clare Lowes
    • Mark Tawn
  • Pain Conditions
    • CRPS
    • Fibromyalgia Solictors
    • Myofascial Pain Syndrome
    • Somatic Symptom Disorder
    • Neuropathic Pain
    • Functional Neurological Disorder (FND)
    • Chronic Fatigue Syndrome (ME)
    • Chronic Pain Syndrome
  • Unhappy With Your Solicitor?
  • Case Studies
    • Testimonials
  • Blog
  • Contact Us
Chronic Pain Feb 1st, 2010

Immune injection treatment blocks chronic pain

A treatment already used for immune diseases like rheumatoid arthritis appears to also work for chronic pain, scientists have discovered.

One small dose of intravenous immunoglobulin (IVIG) reduced pain in just under half of patients treated.

The pain relief lasted five weeks, on average, with few or no side effects, Annals of Internal Medicine reports.

The Liverpool University experts now plan bigger trials on more patients with Complex Regional Pain Syndrome.

Also known as Reflex Sympathetic Dystrophy, Complex Regional Pain syndrome (CRPS) involves a malfunction of the nervous system that causes often unrelenting pain. It usually develops after an injury or trauma to a limb, and continues after the injury has healed.

Experts are not entirely sure why some people develop CRPS, but the latest discovery of how to treat it suggests it might be partly down to inflammation and a heightened immune response to the damage.

The immunoglobulin treatment contains blood antibodies that help dampen inflammation.

The team at Liverpool’s Pain Research Institute tested the treatment on 13 of their patients who had been experiencing chronic pain for the past six months at least.

Although the treatment did not work for every single patient, for many it provided significant relief.

Lead researcher Dr Andreas Goebel said the real effect of this treatment in clinic may turn out to be even greater because the therapy can be given in higher doses, and repeated treatment may have additional effects.

“IVIG is normally repeated every four weeks and we are working to develop ways which would allow patients to administer the treatment in their own home,” he said.

Professor Franz Blaes, of the University of Giesseu in Germany, has also been trialling the treatment in CRPS patients.

He said: “We have seen the same in our patients in more acute stages of the disease. Some of the patients really do benefit – probably between thirty and fifty percent of them.

“It may be that stopping the inflammation stops the problem.

“It is quite an expensive treatment and, as yet, we are not able to tell who will respond until we try it. But we are working on that.”

Longstanding CRPS affects about 1 in 5,000 people in the UK.

Source: BBC

Richard Lowes
Make an Enquiry

Contact Us

Contact Form

Left Column

Right Column

Centre

 
Sending

Recent Articles

  • What are medically unexplained symptoms?
  • Early stage CRPS may respond well to a compound analgesic cream
  • Medical cannabis for chronic pain: NICE block NHS prescriptions
  • Dorsal Root Ganglion Stimulation (DRG) is “effective” and “safe” says new study
  • New study sheds light on distorted body representations in CRPS

Share this Article

Newsletter Sign-up

* indicates required

You may also like...

  • Jan 1st, 2010
    Controlled breathing can help Fibromyalgia patients
    Read Article
  • Mar 1st, 2010
    Opioid Therapy for chronic pain
    Read Article
View All Related Articles

Get in Touch Today

Contact Form

Left Column

Right Column

Centre

 
Sending

1 Edgar Buildings,
George Street,
Bath, BA1 2DU

01225 462871 01225 445060
Authorised & Regulated by Solicitors Regulation Authority (No. 636644).
©2019 BLB Solicitors  |  Privacy & Terms